Osisko Gold Royalties Ltd - OR

OR Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
OR	-0.3	-4.8	-7.5	7.3	11.3	50.2	38.8	116.0	41.1	23.1
S&P 500	-1.3	-2.3	0.5	5.7	10.7	30.1	25.2	88.0	187.6	33142.5

Compare OR with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	OR
name	Osisko Gold Royalties Ltd
price	18.53
changes percentage	-0.32
change	-0.06
day low	18.38
day high	18.70
year high	21.29
year low	12.20
market cap	3457920360
price avg 50	19.17
price avg 200	16.92
exchange	NYSE
volume	4642314
avg volume	571643
open	18.62
previous close	18.59
eps	-0.21
pe	-88.24
earnings announcement	2025-02-18T05:00:00.000+0000
shares outstanding	186612000
timestamp	2024-11-15 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 36.0%

Overall Quarterly Financial Health: 59.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001627272
revenue	247320000	217809000	13.55
gross profit	173059000	150378000	15.08
gross profit ratio	0.7	0.69	1.35
research and development expenses	0	5375000	-100.00
operating expenses	143020000	25591000	458.87
interest income	6831000	9767000	-30.06
interest expense	18946000	22339000	-15.19
ebitda	155679000	187877000	-17.14
ebitdaratio	0.63	0.85	-25.93
operating income	87654000	122969000	-28.72
operating income ratio	0.35	0.56	-37.22
net income	-48343000	85285000	-156.68
net income ratio	-0.2	0.39	-149.92
eps	-0.26	0.47	-155.32

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 247 million in 2023 from 218 million in 2022 representing a change of 13.55%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 173 million in 2023 from 150 million in 2022 representing a change of 15.08%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 143 million in 2023 from 26 million in 2022 representing a change of 458.87%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 88 million in 2023 from 123 million in 2022 representing a change of -28.72%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 5 million in 2022 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 156 million in 2023 from 188 million in 2022 representing a change of -17.14%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to -48 million in 2023 from 85 million in 2022 representing a change of -156.68%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.26 in 2023 from -0.26 in 2022 representing a change of -155.32%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001627272
revenue	57255000	64846000	-11.71
gross profit	45598000	62620000	-27.18
gross profit ratio	0.8	0.97	-17.53
research and development expenses	1506000	0	NaN
operating expenses	8190000	86701000	-90.55
interest income	1591000	1245000	27.79
interest expense	2262000	2839000	-20.32
ebitda	38290000	-16635000	330.18
ebitdaratio	0.67	-0.26	360.69
operating income	37408000	-24081000	255.34
operating income ratio	0.65	-0.37	275.94
net income	18288000	-21115000	186.61
net income ratio	0.32	-0.33	198.09
eps	0.1	-0.11	189.27

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 57 million in 2024Q3 from 65 million in 2024Q2 representing a change of -11.71%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 46 million in 2024Q3 from 63 million in 2024Q2 representing a change of -27.18%. This indicates a sales profitability decline, which is a negative sign for the company.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 2 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 8 million in 2024Q3 from 87 million in 2024Q2 representing a change of -90.55%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 38 million in 2024Q3 from -17 million in 2024Q2 representing a change of 330.18%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 37 million in 2024Q3 from -24 million in 2024Q2 representing a change of 255.34%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 18 million in 2024Q3 from -21 million in 2024Q2 representing a change of 186.61%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.1 in 2024Q3 from 0.1 in 2024Q2 representing a change of 189.27%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001627272
total assets	1965987000	1996301000	-1.52
total liabilities	315489000	259090000	21.77
total equity	1650498000	1737211000	-4.99
cash and cash equivalents	67721000	90548000	-25.21
short term investments	8200000	0	NaN
long term investments	208676000	393267000	-46.94
total current assets	84045000	104794000	-19.80
total non current assets	1923388000	1891507000	1.69
total current liabilities	20452000	17867000	14.47
total non current liabilities	295037000	241223000	22.31
common stock	2097691000	2076070000	1.04
retained earnings	-554697000	-463589000	-19.65
total debt	199880000	155572000	28.48

Overall Score of Annual Balance Sheet

0.2 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,966 million in 2023 from 1,996 million in 2022 representing a change of -1.52%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 315 million in 2023 from 259 million in 2022 representing a change of 21.77%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 1,650 million in 2023 from 1,737 million in 2022 representing a change of -4.99%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 68 million in 2023 from 91 million in 2022 representing a change of -25.21%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 84 million in 2023 from 105 million in 2022 representing a change of -19.8%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 20 million in 2023 from 18 million in 2022 representing a change of 14.47%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -555 million in 2023 from -464 million in 2022 representing a change of -19.65%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 200 million in 2023 from 156 million in 2022 representing a change of 28.48%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Short Term Investments: Short Term Investments increased to 8 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Common Stock: Common Stock increased to 2,098 in 2023 from 2,076 in 2022 representing a change of 1.04%. This indicates an increase in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001627272
total assets	1870570000	1891654000	-1.11
total liabilities	207168000	228451000	-9.32
total equity	1663402000	1663203000	0.01
cash and cash equivalents	58540000	65724000	-10.93
short term investments	15567000	14466000	7.61
long term investments	185077000	197004000	-6.05
total current assets	83957000	88071000	-4.67
total non current assets	1786613000	1803583000	-0.94
total current liabilities	19101000	17894000	6.75
total non current liabilities	188067000	210557000	-10.68
common stock	2113691000	2111335999	0.11
retained earnings	-579252000	-585082000	1.00
total debt	87917000	116418000	-24.48

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,871 million in 2024Q3 from 1,892 million in 2024Q2 representing a change of -1.11%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 59 million in 2024Q3 from 66 million in 2024Q2 representing a change of -10.93%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 84 million in 2024Q3 from 88 million in 2024Q2 representing a change of -4.67%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 19 million in 2024Q3 from 18 million in 2024Q2 representing a change of 6.75%. This indicates a higher short-term debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 207 million in 2024Q3 from 228 million in 2024Q2 representing a change of -9.32%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1,663 million in 2024Q3 from 1,663 million in 2024Q2 representing a change of 0.01%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 16 million in 2024Q3 from 14 million in 2024Q2 representing a change of 7.61%. This indicates an increase in short-term investment holdings.

  Common Stock: Common Stock increased to 2,114 in 2024Q3 from 2,111 in 2024Q2 representing a change of 0.11%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -579 million in 2024Q3 from -585 million in 2024Q2 representing a change of 1.0%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 88 million in 2024Q3 from 116 million in 2024Q2 representing a change of -24.48%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001627272
net change in cash	-22827000	-25150000	9.24
operating cash flow	187027000	109947000	70.11
free cash flow	-104081000	-14262000	-629.78
capital expenditure	-291108000	-124209000	-134.37
depreciation and amortization	57615000	52415000	9.92
deferred income tax	10672000	26688000	-60.01
stock based compensation	10407000	7119000	46.19
accounts payables	1975000	1689000	16.93
inventory	0	0	NaN
acquisitions net	0	-133138000	100.00
investments in property plant and equipment	-291108000	-124209000	-134.37
net cash used for investing activites	-219836000	-381861000	42.43
debt repayment	46709000	-266161000	117.55
common stock issued	12845000	311962000	-95.88
common stock repurchased	-973000	-22135000	95.60
dividends paid	-39903000	-37929000	-5.20
net cash used provided by financing activities	14310000	219237000	-93.47
cash at end of period	67721000	90548000	-25.21
accounts receivables	-4564000	-4844000	5.78
cash at beginning of period	90548000	115698000	-21.74

Overall Score of Annual Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -23 million in 2023 from -25 million in 2022 representing a change of 9.24%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 187 million in 2023 from 110 million in 2022 representing a change of 70.11%. This indicates that the company generated more cash from its core business operations.

  Capital Expenditure: Capital Expenditure decreased to -291 million in 2023 from -124 million in 2022 representing a change of -134.37%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Free Cash Flow: Free Cash Flow decreased to -104 million in 2023 from -14 million in 2022 representing a change of -629.78%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 10 million in 2023 from 7 million in 2022 representing a change of 46.19%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 2 million in 2023 from 2 million in 2022 representing a change of 16.93%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -5 in 2023 from -5 million in 2022 representing a change of 5.78%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -40 million in 2023 from -38 million in 2022 representing a change of -5.2%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001627272
operating cash flow	47201000	52318000	-9.78
free cash flow	32824000	52318000	-37.26
capital expenditure	-14377000	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	7024000	-9534000	173.67
stock based compensation	2158000	2261000	-4.56
accounts receivables	-2247000	-2243000	-0.18
accounts payables	0	-362000	100.00
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-14377000	0	NaN
net cash used for investing activites	-15727000	-5070000	-210.20
debt repayment	-27339000	-44238000	38.20
common stock issued	0	2737000	-100.00
common stock repurchased	-585000	0	NaN
dividends paid	-10747000	-10130000	-6.09
net cash used provided by financing activities	-38112000	-52608000	27.55
net change in cash	-7184000	-4877000	-47.30
cash at end of period	58540000	65724000	-10.93
cash at beginning of period	65724000	70601000	-6.91

Overall Score of Quarterly Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -7 million in 2024Q3 from -5 million in 2024Q2 representing a change of -47.3%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 47 million in 2024Q3 from 52 million in 2024Q2 representing a change of -9.78%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 33 million in 2024Q3 from 52 million in 2024Q2 representing a change of -37.26%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 7 million in 2024Q3 from -10 million in 2024Q2 representing a change of 173.67%. This indicates that the company's tax liability for future periods has increased.

  Dividends Paid: Dividends Paid decreased to -11 million in 2024Q3 from -10 million in 2024Q2 representing a change of -6.09%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -14 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 2 million in 2024Q3 from 2 million in 2024Q2 representing a change of -4.56%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -2 million in 2024Q3 from -2 million in 2024Q2 representing a change of -0.18%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	1.34	1.21	10.59
net income per share	-0.26	0.47	-155.21
operating cash flow per share	1.01	0.61	65.67
free cash flow per share	-0.56	-0.08	-610.76
cash per share	0.41	0.5	-18.34
book value per share	8.91	9.63	-7.47
tangible book value per share	8.31	9.01	-7.80
shareholders equity per share	8.91	9.63	-7.47
interest debt per share	1.14	0.94	20.58
market cap	3501804516.54	2948531437.02	18.76
enterprise value	3633963516.54	3013555437.02	20.59
pe ratio	-72.44	34.57	-309.52
price to sales ratio	14.16	13.54	4.59
pocfratio	18.72	26.82	-30.18
pfcf ratio	-33.64	-206.74	83.73
pb ratio	2.12	1.7	25.00
ptb ratio	2.12	1.7	25.00
ev to sales	14.69	13.84	6.20
enterprise value over ebitda	23.34	16.04	45.53
ev to operating cash flow	19.43	27.41	-29.11
ev to free cash flow	-34.91	-211.3	83.48
earnings yield	-0.01	0.03	-147.73
free cash flow yield	-0.03	-0.0	-514.48
debt to equity	0.12	0.09	36.51
debt to assets	0.1	0.07	31.69
net debt to ebitda	0.85	0.35	145.28
current ratio	4.11	5.87	-29.94
interest coverage	4.63	5.5	-15.95
income quality	-3.87	1.29	-400.10
dividend yield	0.01	0.01	-11.42
payout ratio	-0.83	0.44	-285.60
sales general and administrative to revenue	0.11	0.09	18.85
research and ddevelopement to revenue	0	0.02	-100.00
intangibles to total assets	0.06	0.06	1.54
capex to operating cash flow	1.56	1.13	37.78
capex to revenue	1.18	0.57	106.40
capex to depreciation	5.05	2.37	113.22
stock based compensation to revenue	0.04	0.03	28.74
graham number	7.23	10.12	-28.53
roic	0.07	0.05	33.30
return on tangible assets	-0.03	0.05	-157.61
graham net net	-1.27	-0.93	-36.93
working capital	63593000	86927000	-26.84
tangible asset value	1539294000	1626007000	-5.33
net current asset value	-231444000	-154296000	-50.00
invested capital	1735024000	205078000	746.03
average receivables	4145000	1693000	144.83
average payables	1894000	5163000	-63.32
average inventory	6500.5	9298000.5	-99.93
days sales outstanding	9.27	3.36	175.52
days payables outstanding	15.43	3.51	340.00
days of inventory on hand	0.06	0.0	1,180,335.22
receivables turnover	39.37	108.47	-63.70
payables turnover	23.65	104.06	-77.27
inventory turnover	5712.38	67431000	-99.99
roe	-0.03	0.05	-159.66
capex per share	1.57	0.69	128.26

• Negative

  ROE: Return on Equity (ROE) decreased to -0.03 on 2023-12-31 from 0.05 on 2022-12-31, representing a change of -159.66%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -72.44 on 2023-12-31 from 34.57 on 2022-12-31, representing a change of -309.52%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 4.11 on 2023-12-31 from 5.87 on 2022-12-31, representing a change of -29.94%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.12 on 2023-12-31 from 0.09 on 2022-12-31, representing a change of 36.51%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
OR
calendar year	2024	2024	NaN
revenue per share	0.31	0.35	-11.71
net income per share	0.1	-0.11	186.61
operating cash flow per share	0.25	0.28	-9.78
free cash flow per share	0.18	0.28	-37.26
cash per share	0.4	0.43	-7.59
book value per share	8.93	8.93	0.01
tangible book value per share	8.34	8.33	0.01
shareholders equity per share	8.93	8.93	0.01
interest debt per share	0.45	0.6	-25.76
market cap	4661728352.34	3939837034.83	18.32
enterprise value	4691105352.34	3990531034.83	17.56
pe ratio	63.73	-46.65	236.61
price to sales ratio	81.42	60.76	34.01
pocfratio	98.76	75.31	31.15
pfcf ratio	142.02	75.31	88.59
pb ratio	2.8	2.37	18.31
ptb ratio	2.8	2.37	18.31
ev to sales	81.93	61.54	33.14
enterprise value over ebitda	122.52	-239.89	151.07
ev to operating cash flow	99.39	76.27	30.30
ev to free cash flow	142.92	76.27	87.37
earnings yield	0.0	-0.01	173.20
free cash flow yield	0.01	0.01	-46.98
debt to equity	0.05	0.07	-25.91
debt to assets	0.04	0.06	-25.06
net debt to ebitda	0.77	-3.05	125.18
current ratio	4.4	4.92	-10.70
interest coverage	16.54	-8.48	294.97
income quality	2.58	-2.48	204.17
dividend yield	0.0	0.0	-10.34
payout ratio	0.59	-0.48	222.49
sales general and administrative to revenue	0.12	0.1	18.90
research and ddevelopement to revenue	0.03	0	NaN
intangibles to total assets	0.06	0.06	1.13
capex to operating cash flow	0.3	0	NaN
capex to revenue	0.25	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0.04	0.03	8.10
graham number	4.44	4.77	-6.93
roic	0.01	-0.01	257.77
return on tangible assets	0.01	-0.01	187.65
graham net net	-0.68	-0.73	6.60
working capital	64856000	70177000	-7.58
tangible asset value	1552198000	1551999000	0.01
net current asset value	-123211000	-140380000	12.23
invested capital	1658239000	1667882000	-0.58
average receivables	12879500	10634500	21.11
average payables	5195000	4792000	8.41
average inventory	0	0.5	-100.00
days sales outstanding	13.68	23.67	-42.21
days payables outstanding	44.62	186.43	-76.07
days of inventory on hand	0	0	NaN
receivables turnover	6.58	3.8	73.04
payables turnover	2.02	0.48	317.83
inventory turnover	0	0	NaN
roe	0.01	-0.01	186.60
capex per share	0.08	0	NaN

• Negative

  ROE: Return on Equity (ROE) increased to 0.01 on 2024-09-30 Q3 from -0.01 on 2024-06-30 Q2, representing a change of 186.60%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 4.40 on 2024-09-30 Q3 from 4.92 on 2024-06-30 Q2, representing a change of -10.70%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 63.73 on 2024-09-30 Q3 from -46.65 on 2024-06-30 Q2, representing a change of 236.61%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.05 on 2024-09-30 Q3 from 0.07 on 2024-06-30 Q2, representing a change of -25.91%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is -2.35 which is lower than current price 18.53, indicates the company may be overvalued.